Class IIOngoingD-0845-2023
Drug recall · June 7, 2023
Sodium Chloride Ophthalmic Solution recall
Why: CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sodium Chloride Ophthalmic Solution, USP, 5%, 50mg/mL, 15 mL bottles, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs
- Lots / codes
All Lots
- Quantity
- N/A
- Company
- Akorn, Inc., Gurnee, IL
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- April 26, 2023 · Voluntary: Firm initiated
- Classified
- June 1, 2023
- Reported
- June 7, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IIOngoingJun 7, 2023Atropine Sulfate Ophthalmic SolutionAkorn, Inc. · D-0779-2023Class IIOngoingJun 7, 2023Acetaminophen & Codeine Phosphate Oral Solution 120mg/12mg/5mLAkorn, Inc. · D-0780-2023Class IIOngoingJun 7, 2023Acetic Acid Otic SolutionAkorn, Inc. · D-0781-2023Class IIOngoingJun 7, 2023Acyclovir Oral SuspensionAkorn, Inc. · D-0782-2023Class IIOngoingJun 7, 2023Albuterol Sulfate SyrupAkorn, Inc. · D-0783-2023Class IIOngoingJun 7, 2023Apraclonidine Ophthalmic Solution 0.5%Akorn, Inc. · D-0784-2023Class IIOngoingJun 7, 2023Artificial Tears SolutionAkorn, Inc. · D-0785-2023Class IIOngoingJun 7, 2023Artificial Tears OintmentAkorn, Inc. · D-0786-2023Class IIOngoingJun 7, 2023Azelastine Hydrochloride Nasal SprayAkorn, Inc. · D-0787-2023Class IIOngoingJun 7, 2023AK-POLY-BACAkorn, Inc. · D-0788-2023Class IIOngoingJun 7, 2023Calcipotriene Topical SolutionAkorn, Inc. · D-0789-2023Class IIOngoingJun 7, 2023Calcitriol Injection 1 mcg/mLAkorn, Inc. · D-0790-2023
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.